Södertälje, Sweden

Anna-Lina Cavallo

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna-Lina Cavallo. Retrieved from https://idiyas.com/inventor/anna-lina-cavallo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anna-Lina Cavallo

Introduction

Anna-Lina Cavallo is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of improved nucleases. His work has implications for various applications, including genetic engineering and therapeutic interventions.

Latest Patents

Anna-Lina Cavallo holds a patent titled "Compositions and Methods for Improved Nucleases." This patent represents his innovative approach to enhancing the efficacy of nucleases, which are essential tools in molecular biology.

Career Highlights

Cavallo is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects that aim to improve healthcare outcomes.

Conclusion

Anna-Lina Cavallo's contributions to the field of biotechnology through his patent and work at AstraZeneca AB highlight his role as an influential inventor. His innovations continue to pave the way for advancements in genetic research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…